Ann: Significant Neuroprotection in Traumatic Brain Injury Study, page-16

his saying why not announce on Friday instead of Monday avoiding the worst day in 5 years for the ASX. But how do you know they didn’t receive the data Friday afternoon ? It’s just by chance it landed on the same day but you need to understand that at current valuation this is pathetic and worth multiples compared to peers, the fundamentals and meat on the bone just got significantly stronger. They clear safety in 3 weeks for first cohort then the company is well on its way to become a billion dollar plus market cap. It’s only going to get stronger especially now that the results from Walter Reed prove up secondary brain indication for the drug.